Axoni develops novel blockchain solutions while focusing on the capital markets industry. In various production implementations, we have demonstrated that our blockchain software can serve multiple asset classes and use cases at the world’s most advanced financial institutions.
Draving Consulting is a Jenkintown, PA-based company in the Computers and Electronics sector.
VOSE CONSULTING US LLC is a Boulder, CO-based company in the Computers and Electronics sector.
Omni-ID is the Original Patent holder and leading provider of passive UHF RFID tags. We`ve solved the challenge of high-value asset identification and tracking across many industries. Omni-ID passive RFID tags with global performance and strong on-metal read range offer an affordable alternative to active RFID. RFID Tags for IT Asset Tracking and Management: RFID asset management makes it easy to track thousands of assets with speed, efficiency, and accuracy impossible to achieve with manual or barcode methods. RFID Tags for Manufacturing & Logistics: RFID applications enable a lean and efficient supply chain with bin-level inventory visibility and real-time movement accuracy. RFID Tags for Tool Tracking: RFID asset management enables tight control of work and tool movement without the inefficiency of manual or barcode job tracking. RFID Tags for Industrial Assets: RFID tracking of cargo and containers enables accurate, global visibility, status and security of cargo across all geographic regions, including movement of goods through warehouse, trucking, railway, shipyard, and ocean transport.
Cure Forward is the vision of a small team in Cambridge, MA. We wanted to create a platform to connect patients with genomic medicine, bringing the possibilities of precision medicine directly in reach. A way to use the best of technology to help people diagnosed with life-altering disease discover all of their options. We want to make it easy for patients to understand the root cause of their conditions and put the knowledge to work. Get their data, find treatment options, including clinical trials. We felt making this happen was worth staying up all night.